⌘K

Login Start Free

Home/Filings/4/0001209191-23-021286

4//SEC Filing

Bitterman Chris T. 4

Accession 0001209191-23-021286

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 5:49 PM ET

Size

5.2 KB

Accession

0001209191-23-021286

Insider Transaction Report

Form 4

Period: 2023-03-24

CUMBERLAND PHARMACEUTICALS INCCPIX

Bitterman Chris T.

Vice Pres Sales & Marketing

Transactions

Award
Options (right to buy)
2023-03-24+5,500→ 12,500 total
Exercise: $1.97From: 2027-03-24Exp: 2033-03-24→ Common Stock (5,500 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001969681

Filing Metadata

Form type: 4
Filed: Mar 26, 8:00 PM ET
Accepted: Mar 27, 5:49 PM ET
Size: 5.2 KB

View on SEC.gov